We are live on ! Find out more
NSPRZ

InspireMD, Inc. Series B Warrants
NSPRZ

Delisted

NSPRZ was delisted on the 14th of March, 2022.

Back to rankings

3 hedge funds and large institutions have $11K invested in InspireMD, Inc. Series B Warrants in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more capital invested

Capital invested by funds: $5K → $11K (+$6K)

0% more funds holding

Funds holding: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$256
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$8K -$256 -25,610 -5%
UBS Group
2
UBS Group
Switzerland
$2K – – –
VF
3
Virtu Financial
New York
$1K +$474 +47,395 New

NSPRZ Hedge Fund Activity: Q2 2020 in Review

3 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q2 2020, worth a combined $11K — up 120% from $5K a quarter earlier.

Fund positioning in NSPRZ was balanced in Q2 2020: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Susquehanna International Group, cutting an estimated $256.

  • 3 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $11K of InspireMD, Inc. Series B Warrants stock for Q2 2020, up 120% quarter-over-quarter.
  • 1 fund opened new InspireMD, Inc. Series B Warrants positions in Q2 2020 and 1 closed out, a net change of 0 holders.
  • The largest InspireMD, Inc. Series B Warrants seller in Q2 2020 was Susquehanna International Group, an estimated $256 sold.

Based on aggregated 13F filings for Q2 2020.